Nurexone Biologic Inc
F:J90
Nurexone Biologic Inc
F:J90
Price:
0.38
EUR
Market Closed
Market Cap:
€25.5m
Cash Flow Statement
Cash Flow Statement
Nurexone Biologic Inc
Nurexone Biologic Inc
Currency: USD
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||
| Net Income |
(0)
|
(0)
|
(6)
|
(7)
|
(8)
|
(9)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(6)
|
(6)
|
(7)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
0
|
0
|
2
|
2
|
4
|
4
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Change in Working Capital |
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
0
|
0
|
|
| Cash from Operating Activities |
(0)
N/A
|
(0)
-14%
|
(4)
-4 297%
|
(5)
-21%
|
(4)
+20%
|
(5)
-21%
|
(1)
+69%
|
(1)
+3%
|
(3)
-109%
|
(4)
-22%
|
(4)
-5%
|
(4)
-1%
|
(5)
-29%
|
(4)
+10%
|
(5)
-4%
|
(5)
-10%
|
|
| Investing Cash Flow | |||||||||||||||||
| Capital Expenditures |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
(2)
|
0
|
0
|
(2)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(2)
N/A
|
0
N/A
|
(2)
N/A
|
(2)
-3%
|
(0)
+95%
|
(0)
-58%
|
(0)
+33%
|
(0)
+50%
|
(0)
-106%
|
(0)
-195%
|
(0)
-24%
|
(1)
-85%
|
(1)
0%
|
(0)
+32%
|
(0)
+15%
|
(0)
+76%
|
|
| Financing Cash Flow | |||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
3
|
3
|
1
|
1
|
(2)
|
(1)
|
1
|
5
|
5
|
6
|
6
|
2
|
4
|
4
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other |
2
|
2
|
3
|
4
|
3
|
3
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
2
N/A
|
2
-6%
|
6
+255%
|
8
+28%
|
4
-43%
|
4
-1%
|
0
-99%
|
(1)
N/A
|
1
N/A
|
6
+389%
|
6
+1%
|
6
+4%
|
6
+2%
|
2
-59%
|
4
+65%
|
4
-5%
|
|
| Change in Cash | |||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Net Change in Cash |
(0)
N/A
|
(0)
+71%
|
0
N/A
|
1
+384%
|
0
-73%
|
(1)
N/A
|
(2)
-146%
|
(2)
-31%
|
(2)
+4%
|
2
N/A
|
2
-10%
|
1
-8%
|
0
-88%
|
(3)
N/A
|
(1)
+57%
|
(2)
-33%
|
|
| Free Cash Flow | |||||||||||||||||
| Free Cash Flow |
(0)
N/A
|
(0)
-14%
|
(4)
-4 351%
|
(5)
-21%
|
(4)
+20%
|
(5)
-22%
|
(2)
+68%
|
(1)
+3%
|
(3)
-110%
|
(4)
-27%
|
(4)
-6%
|
(4)
-8%
|
(6)
-24%
|
(5)
+12%
|
(5)
-3%
|
(5)
-4%
|
|
Switch to:
Switch to:
See Also
Discover More
